These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 27215149)

  • 1. Fibroblast growth factor 23 in acute burn patients: Novel insights from an intact-form assay.
    Rousseau AF; Souberbielle JC; Delanaye P; Damas P; Cavalier E
    Burns; 2016 Aug; 42(5):1082-1087. PubMed ID: 27215149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cholecalciferol recommended daily allowances on vitamin D status and fibroblast growth factor-23: an observational study in acute burn patients.
    Rousseau AF; Damas P; Ledoux D; Cavalier E
    Burns; 2014 Aug; 40(5):865-70. PubMed ID: 24462294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low serum iron is associated with high serum intact FGF23 in elderly men: The Swedish MrOS study.
    Lewerin C; Ljunggren Ö; Nilsson-Ehle H; Karlsson MK; Herlitz H; Lorentzon M; Ohlsson C; Mellström D
    Bone; 2017 May; 98():1-8. PubMed ID: 28212898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intact FGF23 and α-Klotho during acute inflammation/sepsis in CKD patients.
    Dounousi E; Torino C; Pizzini P; Cutrupi S; Panuccio V; D'Arrigo G; Abd ElHafeez S; Tripepi G; Mallamaci F; Zoccali C
    Eur J Clin Invest; 2016 Mar; 46(3):234-41. PubMed ID: 26728476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation between Red Cell Distribution Width and Fibroblast Growth Factor 23 Cleaving in Patients with Chronic Kidney Disease and Heart Failure.
    van Breda F; Emans ME; van der Putten K; Braam B; van Ittersum FJ; Kraaijenhagen RJ; de Borst MH; Vervloet M; Gaillard CA
    PLoS One; 2015; 10(6):e0128994. PubMed ID: 26079688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women.
    Wolf M; Koch TA; Bregman DB
    J Bone Miner Res; 2013 Aug; 28(8):1793-803. PubMed ID: 23505057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma fibroblast growth factor 23 concentration and iron status. Does the relationship exist in the elderly population?
    Bożentowicz-Wikarek M; Kocełak P; Owczarek A; Olszanecka-Glinianowicz M; Mossakowska M; Skalska A; Więcek A; Chudek J
    Clin Biochem; 2015 Apr; 48(6):431-6. PubMed ID: 25583093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations Between Intravenous Iron, Inflammation and FGF23 in Non-Dialysis Patients with Chronic Kidney Disease Stages 3-5.
    Muras-Szwedziak K; Nowicki M
    Kidney Blood Press Res; 2018; 43(1):143-151. PubMed ID: 29444509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast Growth Factor 23 (FGF23) and Klotho Protein in Beta-Thalassemia.
    Stefanopoulos D; Nasiri-Ansari N; Dontas I; Vryonidou A; Galanos A; Psaridi L; Fatouros IG; Mastorakos G; Papavassiliou AG; Kassi E; Tournis S
    Horm Metab Res; 2020 Mar; 52(3):194-201. PubMed ID: 32215890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intact and C-Terminal FGF23 Assays-Do Kidney Function, Inflammation, and Low Iron Influence Relationships With Outcomes?
    Sharma S; Katz R; Bullen AL; Chaves PHM; de Leeuw PW; Kroon AA; Houben AJHM; Shlipak MG; Ix JH
    J Clin Endocrinol Metab; 2020 Dec; 105(12):e4875-85. PubMed ID: 32951052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability and degradation of fibroblast growth factor 23 (FGF23): the effect of time and temperature and assay type.
    El-Maouche D; Dumitrescu CE; Andreopoulou P; Gafni RI; Brillante BA; Bhattacharyya N; Fedarko NS; Collins MT
    Osteoporos Int; 2016 Jul; 27(7):2345-2353. PubMed ID: 26928188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration of Ferric Citrate Hydrate Decreases Circulating FGF23 Levels Independently of Serum Phosphate Levels in Hemodialysis Patients with Iron Deficiency.
    Iguchi A; Kazama JJ; Yamamoto S; Yoshita K; Watanabe Y; Iino N; Narita I
    Nephron; 2015; 131(3):161-6. PubMed ID: 26551233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor 23 concentrations and modifying factors in children from age 12 to 24 months.
    Enlund-Cerullo M; Hauta-Alus H; Valkama S; Rosendahl J; Andersson S; Mäkitie O; Holmlund-Suila E
    Bone; 2020 Dec; 141():115629. PubMed ID: 32919110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast growth factor 23 is pumping iron: C-terminal-fibroblast growth factor 23 cleaved peptide and its function in iron metabolism.
    Courbon G; David V
    Curr Opin Nephrol Hypertens; 2024 Jul; 33(4):368-374. PubMed ID: 38661434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production.
    David V; Martin A; Isakova T; Spaulding C; Qi L; Ramirez V; Zumbrennen-Bullough KB; Sun CC; Lin HY; Babitt JL; Wolf M
    Kidney Int; 2016 Jan; 89(1):135-46. PubMed ID: 26535997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spleen contributes significantly to increased circulating levels of fibroblast growth factor 23 in response to lipopolysaccharide-induced inflammation.
    Bansal S; Friedrichs WE; Velagapudi C; Feliers D; Khazim K; Horn D; Cornell JE; Werner SL; Fanti P
    Nephrol Dial Transplant; 2017 Jun; 32(6):960-968. PubMed ID: 27836924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex and Iron Modify Fibroblast Growth Factor 23 Concentration in 1-Year-Old Children.
    Holmlund-Suila E; Enlund-Cerullo M; Valkama S; Hauta-Alus H; Rosendahl J; Helve O; Hytinantti T; Viljakainen H; Andersson S; Mäkitie O
    J Clin Endocrinol Metab; 2017 Dec; 102(12):4526-4533. PubMed ID: 29029193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological variability of plasma intact and C-terminal FGF23 measurements.
    Smith ER; Cai MM; McMahon LP; Holt SG
    J Clin Endocrinol Metab; 2012 Sep; 97(9):3357-65. PubMed ID: 22689697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of acute kidney injury and chronic hypoxemia on fibroblast growth factor 23 levels in pediatric cardiac surgery patients.
    Hanudel MR; Wesseling-Perry K; Gales B; Ramos G; Campbell V; Ethridge K; Scotti M; Elashoff DA; Alejos J; Reemtsen B; Salusky IB
    Pediatr Nephrol; 2016 Apr; 31(4):661-9. PubMed ID: 26525200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Faces of Fibroblast Growth Factor 23 (FGF23): Iron Deficiency, Inflammation, Insulin Resistance, Left Ventricular Hypertrophy, Proteinuria and Acute Kidney Injury.
    Kanbay M; Vervloet M; Cozzolino M; Siriopol D; Covic A; Goldsmith D; Solak Y
    Calcif Tissue Int; 2017 Mar; 100(3):217-228. PubMed ID: 27826644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.